These data confirmed those of other studies reporting that TP53 mutations are most frequent in HBV than in HCV-related HCC; 30–40% in HBV vs. 20% of patients with HCV-associated HCC [89,90]. The gene discussed is TP53; the disease is hepatocellular carcinoma.